GENETON
Paternity and genetic testing, bioinformatics analyses and NGS-based clinical diagnostics for clients in Slovakia
About GENETON
Geneton offers paternity DNA tests (anonymous and forensic, before and after birth), genetic tests using next-generation sequencing and capillary electrophoresis fragment analysis, and bioinformatics analyses including variant, virus and transcriptomic analysis. The website also lists Sanger sequencing and DNA identity tests.
The website publishes a price list valid from 14 January 2025, with paternity tests priced per test and surcharges for non-standard samples, express analysis and additional children or potential fathers. The text does not describe customer segments or revenue model beyond these service prices.
The company is registered in Bratislava as GENETON s.r.o., founded in 2006, and the registry lists it as a subsidiary of a foreign group. The website does not state office locations or hiring activity.
Product: Paternity DNA tests, genetic tests (NGS and fragment analysis), Sanger sequencing and bioinformatics analyses
Financials
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Revenue | €365k | €1.4M | €1.2M | €351k | €587k |
| Growth | −73% | +15% | +240% | −40% | — |
| EBITDA | −€336k | €190k | €131k | €47k | €23k |
| Operating profit | −€505k | €39k | €88k | €42k | €11k |
| Net profit | −€524k | €27k | €60k | €19k | €4k |
| Net margin | −143.7% | 2% | 5% | 5.4% | 0.7% |
| Personnel costs | €655k | €704k | €538k | €621k | €637k |
| Total assets | €1.4M | €1.5M | €1.9M | €2.7M | €2.5M |
| Cash | €59k | €256k | €539k | €380k | €838k |
| Liabilities | €550k | €178k | €558k | €361k | €216k |
| Equity | −€125k | €400k | €373k | €352k | €195k |
As filed with RÚZ (Slovak register of financial statements). Each year links to its statement.
Public contracts
Contracts GENETON signed since 1 Nov 2024, from the Slovak and Czech public contract registers. Values as published; amendments are not counted.
Customers
3 contracts with 3 buyers · €443k
| Contracts | Value | |
|---|---|---|
| Agentúra na podporu výskumu a vývoja | 1 | €299k |
| Výskumná agentúra | 1 | €108k |
| Univerzita Komenského v Bratislave - Lekárska fakulta | 1 | €35k |
Open public tenders for GENETON →
Suppliers
1 contract with 1 supplier · €96k
| Contracts | Value | |
|---|---|---|
| Biomedicínske centrum Slovenskej akadémie vied, v. v. i. | 1 | €96k |
Latest contracts
- 3 Nov 2025 from Biomedicínske centrum Slovenskej akadémie vied, v. v. i. · Zmluva o spolupráci na riešení projektu a o podmienkach poskytnutia prostriedkov na riešenie projektu č. APVV-24-0284 · €96k register
- 17 Oct 2025 for Agentúra na podporu výskumu a vývoja · ZMLUVA O POSKYTNUTÍ PROSTRIEDKOV č. APVV-24-0284 · €299k register
- 11 Apr 2025 for Výskumná agentúra · ZMLUVA O POSKYTNUTÍ PROSTRIEDKOV MECHANIZMU NA PODPORU OBNOVY A ODOLNOSTI · €108k register
- 12 Nov 2024 for Univerzita Komenského v Bratislave - Lekárska fakulta · Zmluva o spolupráci na riešení projektu č. APVV-23-0611 · €35k register
Public tenders won
2 tenders won since 1 Jan 2024 from 1 public buyer in Czechia, worth 31.1M CZK as awarded. From EU award notices (TED) that name GENETON by its registry number.
- 28 Apr 2026 Institute of Applied Biotechnologies a.s. · DiPha: Komplet softwarových nástrojů a jejich aplikací pro predikci a vedení účelné farmakoterapie pomocí digitalizované informace o farmakogenetických aspektech a lékových interakcích · 7.3M CZK notice
- 15 Jul 2024 Institute of Applied Biotechnologies a.s. · CeDiGe 2024 · 23.8M CZK notice
Jobs at GENETON
Leadership
- Radim Bobek · Konateľ (Managing director)Source: business register
More biotech & pharma companies
Gensity
DNA species identification and eDNA biodiversity analysis for environmental monitoring in SlovakiaYoung companyProfitableGrowingGlycanostics
Blood-based glycan test for early prostate cancer detection, aimed at reducing unnecessary biopsies for menhameln rds
EU GMP contract manufacturer of APIs and highly potent APIs, with QC, stability and regulatory services for pharma companiesProfitableIBSA Slovakia
Pharmaceutical products for patients and healthcare professionals in SlovakiaProfitableINTEC PHARMA
Pharmaceutical distributor supplying medicines and medical devices to pharmacies and hospitals in SlovakiaProfitableNew on EvolcJUHAPHARM
Pharmaceutical distribution, product development and industrial R&D for healthcare and industry clientsProfitableNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Forms
- Contact Form 7High confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- Google reCAPTCHAHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- BootstrapHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- nginxHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.